SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,687,593 | -25.3% | 387,653 | -18.6% | 0.07% | -18.1% |
| Q2 2023 | $14,309,732 | -16.8% | 476,039 | +0.3% | 0.08% | -18.6% |
| Q1 2023 | $17,202,837 | +1.7% | 474,823 | +0.1% | 0.10% | +1.0% |
| Q4 2022 | $16,918,388 | +1.7% | 474,303 | -3.4% | 0.10% | -7.3% |
| Q3 2022 | $16,628,000 | +20.8% | 491,240 | +3.2% | 0.11% | +34.6% |
| Q2 2022 | $13,767,000 | -14.0% | 476,041 | -3.9% | 0.08% | +3.8% |
| Q1 2022 | $16,002,000 | +19.8% | 495,115 | +8.1% | 0.08% | +14.7% |
| Q4 2021 | $13,360,000 | +28.6% | 458,155 | +17.7% | 0.07% | +17.2% |
| Q3 2021 | $10,385,000 | – | 389,405 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |